What price to pay? The cost of everything and the value of nothing

Circulation

Volumn 119, Issue 3, 2009, Pages 368-370

  Ezekowitz, Justin A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cost benefit analysis; Editorials; Heart failure; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; EPLERENONE;

BARE METAL STENT; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG ELUTING STENT; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH STATUS; HEART FAILURE; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; MEDICAL CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVASCULARIZATION; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION; SURVIVAL RATE; CARDIOVASCULAR DISEASE; ECONOMICS; NOTE;

CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS;

EID: 60549105535     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.830679     Document Type: Editorial

References (16)

1. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.
2. Chang WC, Kaul P, Fu Y, Westerhout CM, Granger CB, Mahaffey KW, Wallentin L, Van de Werf F, Armstrong PW, for the ASSENT-3 Investigators. Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction. Ear Heart J. 2006;27:419-426.
3. Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D Jr, O'Neill WW, Todaro TG, Vahanian A, Van de Werf F. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007;297:43-51.
4. World Health Organization. Preventing Chronic Diseases: A Vital investment. Geneva, Switzerland: World Health Organization; 2005.
5. Chan PS, Soto G, Jones PG, Nallamothu BK, Zhang Z, Weintraub WS, Spertus JA. Patient health status and costs in heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2009;119:398-407.
6. Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007;115:1975-1981.
7. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245-1255.
8. Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MGM, Goldman L. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002;346: 1800-1806.
9. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030-1039.
10. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:989-997.
11. Ryan J, Cohen DJ. Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation. 2006;114:1736-1743.
12. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, for the COURAGE Trial Research Group. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359:677-687.
13. Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol. 2009;53:13-20.
14. Hebert PL, Sisk JE, Wang JJ, Tuzzio L, Casablanca JM, Chassin MR, Horowitz C, McLaughlin MA. Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community. Ann Intern Med. 2008;149:540-548.
15. Capomolla S, Febo O, Ceresa M, Caporotondi A, Guazzotti G, La Rovere MT, Ferrari M, Lenta F, Baldin S, Vaccarini C, Gnemmi M, Pinna G, Maestri R, Abelli P, Verdirosi S, Cobelli F. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care. J Am Coll Cardiol. 2002;40:1259-1266.
16. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44:810-819.